Floatz logo

18 assets in Neutropenia

Therapeutic assets addressing Neutropenia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Nivestim
Neutropenia
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP4BBB (76)
Cefepime
Neutropenia
Hospital Universitari Vall d'Hebron Research InstituteP4BB (70)
Etoposide
Neutropenia
Shandong Cancer Hospital and InstituteP3BB (65)
ql0605
Neutropenia
Qilu Pharmaceutical Co., Ltd.P4BB (65)
Ciprofloxacin
Neutropenia
Hospital Universitari Vall d'Hebron Research InstituteP4B (63)
Carboplatin
Neutropenia
Shandong Cancer Hospital and InstituteP3B (61)
Cis-Diamminedichloroplatinum Ii
Neutropenia
Shandong Cancer Hospital and InstituteP3B (61)
Dexasone
Neutropenia
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2B (60)
Lenalidomide
Neutropenia
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2B (58)
Mavorixafor
Neutropenia
X4 PharmaceuticalsP3B (57)
Efbemalenograstim Alfa
Neutropenia
Henan Cancer HospitalP2CCC (53)
Telpegfilgrastim
Neutropenia
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (53)
Umbilical Cord Derived Mesenchymal Stem Cells Exosomes
Neutropenia
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP1CC (41)
Sulpegfilgrastim
Neutropenia
The First Affiliated Hospital of Soochow UniversityN/AD (30)
Peg-G-Csf
Neutropenia
Kexing Biopharm Co., Ltd.P3NR ()